A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Intravenous NA-1 Initiated by Paramedics in the Field for Acute Cerebral Ischemia Within Three Hours of Symptom Onset

Trial Profile

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Intravenous NA-1 Initiated by Paramedics in the Field for Acute Cerebral Ischemia Within Three Hours of Symptom Onset

Recruiting
Phase of Trial: Phase III

Latest Information Update: 09 May 2016

At a glance

  • Drugs NA 1 (Primary)
  • Indications Stroke
  • Focus Therapeutic Use
  • Acronyms FRONTIER
  • Sponsors NoNO
  • Most Recent Events

    • 04 May 2016 Planned End Date changed from 1 Mar 2017 to 1 May 2019.
    • 04 May 2016 Planned primary completion date changed from 1 Mar 2017 to 1 Mar 2019.
    • 19 Feb 2016 Trial design presented at the 41st International Stroke Conference
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top